The current PE ratio of ENOV can't be determined, as the TTM EPS of -$0.61 is negative. The last PE ratio of Enovis, recorded in September 2022, was 112.37.
The PE ratio of Enovis has averaged 44.66 over the last ten years. In the past ten years, ENOV's PE ratio reached its highest point in the Dec 2020 quarter at 123.36, when the stock price was $114.72 and the EPS was $0.93. The lowest point was recorded in the Mar 2015 quarter, when it reached 14.85 with a price of $143.04 and an EPS of $9.63.
Maximum annual increase: 99.71% in 2016
Maximum annual decrease: -58.73% in 2014
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | N/A | N/A |
| 2021 | 98.51 | -20.14% |
| 2020 | 123.36 | N/A |
| 2019 | N/A | N/A |
| 2018 | 17.86 | -44.55% |
| 2017 | 32.21 | -6.77% |
| 2016 | 34.55 | 99.71% |
| 2015 | 17.3 | 2.67% |
| 2014 | 16.85 | -58.73% |
| Stock name | PE ratio | Market cap |
|---|---|---|
| NVRO Nevro Corp | N/A | $415.66M |
| OFIX Orthofix Medical Inc | N/A | $489.65M |
| NURO NeuroMetrix Inc | N/A | $9.34M |
| ENOV Enovis Corp | N/A | $3.05B |
The current price to earnings ratio of ENOV can't be calculated, as its EPS of -$0.61 is negative.
As an average over the last 3 years, ENOV stock has a PE ratio of 78.11.
As an average over the last 5 years, ENOV stock has a PE ratio of 87.31.
Over the last ten years, the quarterly PE ratio reached a historic high of 123.36 in the Dec 2020 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.